To provide the Food and Drug Administration needed authorities to carry out its regulatory mission with respect to human foods, to provide additional resources and authorities with respect to human foods research, and for other purposes.

(a) Sense of Congress. It is the sense of Congress that an account, to be known as the Human Foods Innovation Account, should be established for purposes of the Food and Drug Administration carrying out the activities described in subsection (b).

(b) FDA activities. The activities described in this subsection are—

(1) the critical research grants under section 4;

(2) the establishment and maintenance of the center of excellence described in section 5;

(3) the public-private partnership under section 8;

(4) the development of modernized standards for human foods, including foods for infants and young children;

(5) the development of modernized standards for enhanced human food safety and supply chain continuity;

(6) advances in human foods nutrition innovation;

(7) the development of strengthened dietary supplement authorities;

(8) research relating to human foods biotechnology;

(9) the development of modernized regulatory tools for chemicals in human foods;

(10) modernizing risk assessment and enhanced risk-informed decision making with respect to human foods;

(11) enhanced technical capacity using hiring authority provided by the Food and Drug Omnibus Reform Act of 2022 (title III of division FF of Public Law 117–328); and

(12) such projects enabling innovation and technological advancements in the human foods sector and a fuller understanding of nutrition, as the Commissioner determines appropriate.